Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PKI Tumor Concentrations in High-grade Glioma
NCT02239952Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2014
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sunitinib, vandetanib and erlotinib in glioma, sponsored by Amsterdam University Medical Center. Status: unknown.
02
Drugs
sunitinibvandetaniberlotinib
03
Conditions
glioma
Beyond the preview
Go deeper on NCT02239952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02239952.